TY - JOUR
T1 - Circumvention of regulatory CD4+ T cell activity during cross-priming strongly enhances T cell-mediated immunity
AU - Heit, Antje
AU - Gebhardt, Friedemann
AU - Lahl, Katharina
AU - Neuenhahn, Michael
AU - Schmitz, Frank
AU - Anderl, Florian
AU - Wagner, Hermann
AU - Sparwasser, Tim
AU - Busch, Dirk H.
AU - Kastenmüller, Kathrin
PY - 2008/6
Y1 - 2008/6
N2 - Immunization with purified antigens is a safe and practical vaccination strategy but is generally unable to induce sustained CD8+ T cell-mediated protection against intracellular pathogens. Most efforts to improve the CD8+ T cell immunogenicity of these vaccines have focused on co-administration of adjuvant to support cross-presentation and dendritic cell maturation. In addition, it has been shown that CD4+ T cell help during the priming phase contributes to the generation of protective CD8+ memory T cells. In this report we demonstrate that the depletion of CD4+ T cells paradoxically enhances long-lasting CD8-mediated protective immunity upon protein vaccination. Functional and genetic in vivo inactivation experiments attribute this enhancement primarily to MHC class II-restricted CD4+ regulatory T cells (Treg), which appear to physiologically suppress the differentiation process towards long-living effector memory T cells. Since, in functional terms, this suppression by Treg largely exceeds the positive effects of conventional CD4+ T cell help, even the absence of all CD4+ T cells or lack ofMHCclass II-mediated interactions on priming dendritic cells result in enhanced CD8+ T cell immunogenicity. These findings have important implications for the improvement of vaccines against intracellular pathogens or tumors, especially in patients with highly active Treg.
AB - Immunization with purified antigens is a safe and practical vaccination strategy but is generally unable to induce sustained CD8+ T cell-mediated protection against intracellular pathogens. Most efforts to improve the CD8+ T cell immunogenicity of these vaccines have focused on co-administration of adjuvant to support cross-presentation and dendritic cell maturation. In addition, it has been shown that CD4+ T cell help during the priming phase contributes to the generation of protective CD8+ memory T cells. In this report we demonstrate that the depletion of CD4+ T cells paradoxically enhances long-lasting CD8-mediated protective immunity upon protein vaccination. Functional and genetic in vivo inactivation experiments attribute this enhancement primarily to MHC class II-restricted CD4+ regulatory T cells (Treg), which appear to physiologically suppress the differentiation process towards long-living effector memory T cells. Since, in functional terms, this suppression by Treg largely exceeds the positive effects of conventional CD4+ T cell help, even the absence of all CD4+ T cells or lack ofMHCclass II-mediated interactions on priming dendritic cells result in enhanced CD8+ T cell immunogenicity. These findings have important implications for the improvement of vaccines against intracellular pathogens or tumors, especially in patients with highly active Treg.
KW - CD8 T cells
KW - Cross-priming
KW - Protective immunity
KW - Regulatory T cells
UR - http://www.scopus.com/inward/record.url?scp=49649106712&partnerID=8YFLogxK
U2 - 10.1002/eji.200737966
DO - 10.1002/eji.200737966
M3 - Article
C2 - 18465771
AN - SCOPUS:49649106712
SN - 0014-2980
VL - 38
SP - 1585
EP - 1597
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 6
ER -